CONSIDERATIONS TO KNOW ABOUT ABBV-744 BRD4 INHIBITOR CANCER THERAPY EFFICACY

These side effects were being notably milder as compared to an inhibitor of the two bromodomains. An in depth molecular Assessment also uncovered that ABBV-744 preferentially inhibits the expression of Androgen Receptor (AR)-dependent genes.  ― Stephen Taylor- "Our study exposed the vital part in the KLF16/MYC regulatory axis in modulating tumor